Abstract
Laboratory registry data (80,791 specimens, 70,517 individuals) was used to characterise age- and sex-specific SARS-CoV-2 RT-PCR sampling frequency and positivity rate, and laboratory capacity building in Greater Helsinki, Finland during February-June 2020. While the number of positive cases was similar in males and females, the positivity rate was significantly higher in males. The highest incidence/100,000 was observed in those aged ≥80 years. The proportion of young adults in positive cases increased in late May 2020.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funded by Helsinki University Hospital, HUSLAB, Helsinki, Finland.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
HUS/157/2020 (Helsinki University Hospital, Finland)
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Conflict of interest: None of the authors have conflict of interest.
Funding statement: Funded by Helsinki University Hospital, HUSLAB, Helsinki, Finland.
Conceptualisation: HJ, SKU, EK, ML. Data curation: HJ, SKU, OL. Formal analysis: HJ, SKU, OL. Funding: ML. Investigation: HJ, ML, OL, AEJ, AJJ, PJ, EK, HKK, LM, HS, SS, AT, CSK, RL, SKU. Methodology: HJ, ML, AEJ, PJ, HKK, LM, RL, SKU. Project administration: HJ, SKU. Resources: ML. Validation: HJ, SKU, ML. Writing - original draft: HJ, SKU. Writing - review & editing, HJ, ML, OL, AEJ, AJJ, PJ, EK, HKK, LM, HS, SS, AT, CSK, RL, SKU. All authors approved the final version of the manuscript.
Data Availability
Data is available upon request.